CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Edge AI Is Reshaping How Clinical Trials Run
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
-
Telehealth In Clinical Trials: What Sites And Patients Think
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
ECOA RESOURCES
-
Join Curebase CEO Tom Lemberg for a live demo of our next-generation ePRO/eCOA technology. See how our AI Assistant lets you build forms, generate translations, and enter data in seconds with our intuitive, user-friendly platform.
-
Electronic Clinical Outcome Assessment (eCOA) has transformed data collection in clinical trials by prioritizing patient engagement and improving data accuracy.
-
A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.
ECONSENT RESOURCES
-
IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.
-
In this episode of Download with Derk, we take an in-depth look at our internal experiment where Castor Companion was utilized during the consent process.
-
EU Annex 11 lays out the European Union’s regulations for using computerized systems during clinical trials. Learn how sponsors and sites seeking treatment approval in the EU must follow Annex 11.
EPRO RESOURCES
-
Join Curebase CEO Tom Lemberg for a live demo of our next-generation ePRO/eCOA technology. See how our AI Assistant lets you build forms, generate translations, and enter data in seconds with our intuitive, user-friendly platform.
-
This study examines participant convenience and compliance, aiming to understand and address the challenges faced by site personnel in global trials.
-
Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.